Filing Flows › Cytokinetics (CYTK) › Recalls, complaints & regulation
Cytokinetics (CYTK): clinical trials
Cytokinetics (CYTK) beyond its filings: 5 active clinical trials.
Cytokinetics' latest quarter
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Cytokinetics have?
5 active studies on ClinicalTrials.gov, 4 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.